These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

667 related articles for article (PubMed ID: 28436193)

  • 1. Association between using medications with anticholinergic properties and short-term cognitive decline among older men: A retrospective cohort study in Taiwan.
    Wu YH; Wang CJ; Hung CH; Chen LY; Lin MH; Wang PN; Chen LK
    Geriatr Gerontol Int; 2017 Apr; 17 Suppl 1():57-64. PubMed ID: 28436193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of living arrangements on clinical outcomes among older patients with dementia or cognitive impairment admitted to the geriatric evaluation and management unit in Taiwan.
    Hung CH; Tang TC; Wang CJ; Liu LK; Peng LN; Chen LK
    Geriatr Gerontol Int; 2017 Apr; 17 Suppl 1():44-49. PubMed ID: 28436194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Slow gait speed as a predictor of 1-year cognitive decline in a veterans' retirement community in southern Taiwan.
    Hsu CL; Liang CK; Liao MC; Chou MY; Lin YT
    Geriatr Gerontol Int; 2017 Apr; 17 Suppl 1():14-19. PubMed ID: 28436187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delaying cognitive and physical decline through multidomain interventions for residents with mild-to-moderate dementia in dementia care units in Taiwan: A prospective cohort study.
    Liang CK; Chou MY; Chen LY; Wang KY; Lin SY; Chen LK; Lin YT; Liu TY; Loh CH
    Geriatr Gerontol Int; 2017 Apr; 17 Suppl 1():36-43. PubMed ID: 28436184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential benefits of reducing medication-related anticholinergic burden for demented older adults: a prospective cohort study.
    Yeh YC; Liu CL; Peng LN; Lin MH; Chen LK
    Geriatr Gerontol Int; 2013 Jul; 13(3):694-700. PubMed ID: 23216534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive factors for dementia and cognitive impairment among residents living in the veterans' retirement communities in Taiwan: Implications for cognitive health promotion activities.
    Chen LY; Wu YH; Huang CY; Liu LK; Hwang AC; Peng LN; Lin MH; Chen LK
    Geriatr Gerontol Int; 2017 Apr; 17 Suppl 1():7-13. PubMed ID: 28436185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of non-pharmacological intervention effect on cognitive function and behavioral and psychological symptoms of older people with dementia.
    Hsu TJ; Tsai HT; Hwang AC; Chen LY; Chen LK
    Geriatr Gerontol Int; 2017 Apr; 17 Suppl 1():28-35. PubMed ID: 28436192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Anticholinergic Drug Burden with Cognitive and Functional Decline Over Time in Older Inpatients: Results from the CRIME Project.
    Brombo G; Bianchi L; Maietti E; Malacarne F; Corsonello A; Cherubini A; Ruggiero C; Onder G; Volpato S
    Drugs Aging; 2018 Oct; 35(10):917-924. PubMed ID: 30191516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective factors against cognitive decline among community-dwelling middle-aged and older people in Taiwan: A 6-year national population-based study.
    Lee WJ; Liang CK; Peng LN; Chiou ST; Chen LK
    Geriatr Gerontol Int; 2017 Apr; 17 Suppl 1():20-27. PubMed ID: 28436186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticholinergic Drug Use and Risk to Cognitive Performance in Older Adults with Questionable Cognitive Impairment: A Cross-Sectional Analysis.
    Swami S; Cohen RA; Kairalla JA; Manini TM
    Drugs Aging; 2016 Nov; 33(11):809-818. PubMed ID: 27638818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticholinergic burden for prediction of cognitive decline or neuropsychiatric symptoms in older adults with mild cognitive impairment or dementia.
    Taylor-Rowan M; Kraia O; Kolliopoulou C; Noel-Storr AH; Alharthi AA; Cross AJ; Stewart C; Myint PK; McCleery J; Quinn TJ
    Cochrane Database Syst Rev; 2022 Aug; 8(8):CD015196. PubMed ID: 35994403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticholinergic Burden and Cognitive Impairment in Nursing Homes: A Comparison of Four Anticholinergic Scales.
    Novella A; Elli C; Ianes A; Pasina L
    Drugs Aging; 2023 Nov; 40(11):1017-1026. PubMed ID: 37620654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticholinergic burden (prognostic factor) for prediction of dementia or cognitive decline in older adults with no known cognitive syndrome.
    Taylor-Rowan M; Edwards S; Noel-Storr AH; McCleery J; Myint PK; Soiza R; Stewart C; Loke YK; Quinn TJ
    Cochrane Database Syst Rev; 2021 May; 5(5):CD013540. PubMed ID: 34097766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atropinic (anticholinergic) burden in antipsychotic-treated patients.
    Montastruc F; Benevent J; Touafchia A; Chebane L; Araujo M; Guitton-Bondon E; Durrieu G; Arbus C; Schmitt L; Begaud B; Montastruc JL
    Fundam Clin Pharmacol; 2018 Feb; 32(1):114-119. PubMed ID: 28887902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticholinergic exposure and cognitive decline in older adults: effect of anticholinergic exposure definitions in a 3-year analysis of the multidomain Alzheimer preventive trial (MAPT) study.
    Andre L; Gallini A; Montastruc F; Coley N; Montastruc JL; Vellas B; Andrieu S; Gardette V;
    Br J Clin Pharmacol; 2019 Jan; 85(1):71-99. PubMed ID: 30098049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug Burden Index and change in cognition over time in community-dwelling older men: the CHAMP study.
    Jamsen KM; Gnjidic D; Hilmer SN; Ilomäki J; Le Couteur DG; Blyth FM; Handelsman DJ; Naganathan V; Waite LM; Cumming RG; Bell JS
    Ann Med; 2017 Mar; 49(2):157-164. PubMed ID: 27763767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticholinergic drugs and functional, cognitive impairment and behavioral disturbances in patients from a memory clinic with subjective cognitive decline or neurocognitive disorders.
    Dauphinot V; Mouchoux C; Veillard S; Delphin-Combe F; Krolak-Salmon P
    Alzheimers Res Ther; 2017 Aug; 9(1):58. PubMed ID: 28764796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of cumulative exposure to anticholinergic and sedative drugs on cognition in older adults: a memory clinic cohort study.
    Reallon E; Gervais F; Moutet C; Dauphinot V; Desnavailles P; Novais T; Krolak-Salmon P; Garnier-Crussard A; Mouchoux C;
    Alzheimers Res Ther; 2024 Jul; 16(1):163. PubMed ID: 39044289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medication Profiles of Patients with Cognitive Impairment and High Anticholinergic Burden.
    Green AR; Reifler LM; Boyd CM; Weffald LA; Bayliss EA
    Drugs Aging; 2018 Mar; 35(3):223-232. PubMed ID: 29404965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. One-Year Evaluation of a Targeted Medication Therapy Management Intervention for Older Adults.
    Martinez AI; Abner EL; Jicha GA; Rigsby DN; Eckmann LC; Huffmyer MJ; Moga DC
    J Manag Care Spec Pharm; 2020 Apr; 26(4):520-528. PubMed ID: 32223601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.